Long-term modification of spasticity 61

[1]  Theo J. B. M. Postma,et al.  Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System , 1999, PharmacoEconomics.

[2]  E. Elovic,et al.  Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. , 2002, The New England journal of medicine.

[3]  F. Sampson,et al.  Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. , 2002, Journal of neurosurgery.

[4]  D. Richardson.  Physical therapy in spasticity. , 2002, European journal of neurology.

[5]  G. Francisco,et al.  Intrathecal baclofen therapy for spastic hypertonia. , 2001, Physical medicine and rehabilitation clinics of North America.

[6]  D. Dawson,et al.  Evidence basis for treatment of spasticity , 2001, Current neurology and neuroscience reports.

[7]  A. Ward.  Assessment of muscle tone. , 2000, Age and ageing.

[8]  Roslyn N. Boyd,et al.  Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy , 1999 .

[9]  M. Hadley,et al.  Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. , 1999, American journal of physical medicine & rehabilitation.

[10]  M. Staal,et al.  Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity , 1997, Journal of neurology, neurosurgery, and psychiatry.

[11]  A. Ward,et al.  THE MANAGEMENT OF SPASTICITY , 1972, British journal of hospital medicine.

[12]  K Albany,et al.  Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity , 1997, Muscle & nerve. Supplement.

[13]  D. Mclellan,et al.  Symptomatic and functional improvement of foot dystonia with medial popliteal nerve block , 1996 .

[14]  D. Mclellan,et al.  The effectiveness of chemical neurolysis in the treatment of lower limb muscle spasticity , 1996 .

[15]  I. Sanders,et al.  Quantifying how location and dose of botulinum toxin injections affect muscle paralysis , 1993, Muscle & nerve.

[16]  W Z Rymer,et al.  Objective quantification of spastic hypertonia: correlation with clinical findings. , 1992, Archives of physical medicine and rehabilitation.

[17]  J. Keenan,et al.  Peripheral nerve block and motor point block with phenol in the management of spasticity. , 1970, Proceedings of the Royal Society of Medicine.

[18]  J. Held,et al.  Rééducation motrice des affections neurologiques , 1969 .